Isolating p16-positive/HPV-negative Oropharyngeal Cancer: An Effort Worth Making

American Journal of Surgical Pathology

Volumn 35, Issue 5, 2011, Pages 774-777

  Perrone, Federica ^a   Gloghini, Annunziata ^a   Cortelazzi, Barbara ^a   Bossi, Paolo ^b   Licitra, Lisa ^b   Pilotti, Silvana ^a  

^a Laboratory Medicine   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR MARKER; VIRUS DNA;

HUMAN; IN SITU HYBRIDIZATION; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; LABORATORY DIAGNOSIS; LETTER; METABOLISM; MORTALITY; OROPHARYNX TUMOR; PAPILLOMAVIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FALSE POSITIVE REACTIONS; HUMANS; IN SITU HYBRIDIZATION; KAPLAN-MEIER ESTIMATE; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 79954597792     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182116a45     Document Type: Letter

References (15)

1. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24-35.
2. Chung CH, Gillison ML. Human papillo-mavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res. 2009;15:6758-6762.
3. Fischer CA, Kampmann M, Zlobec I, et al. P16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging para-meters. Ann Oncol. 2010;21:1961-1966.
4. Fischer CA, Zlobec I, Green E, et al. Is the improved prognosis of p16 positive oro-pharyngeal squamous cell carcinoma de-pendent on the treatment modality? Int J Cancer. 2010;126:1256-1262.
5. Gao X, Chen L. Human papillomavirus and oropharyngeal cancer survival. N Engl J Med. 2010;363:1576.
6. Hoffmann M, Ihloff AS, Gorogh T, et al. p16(INK4a) overexpression predicts trans-lational active human papillomavirus infec-tion in tonsillar cancer. Int J Cancer. 2010;127:1595-1602.
7. Korn EL, Dorey FJ. Applications ofcrude incidence curves. Stat Med. 1992;11: 813-829.
8. Kreimer AR, Clifford GM, Boyle P, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14:467-475. (Pubitemid 40270113)
9. Lewis JS Jr, Thorstad WL, Chernock RD, et al. p16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol. 2010;34:1088-1096.
10. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prog-nosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006;24:5630-5636. (Pubitemid 46631302)
11. Licitra L, Zigon G, Gatta G, et al. Human papilloma virus in HNSCC: a European epidemiologic perspective. Hematol Oncol Clin North Am. 2008;22:1143-1153.
12. Perrone F, Suardi S, Pastore E, et al. Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma. Clin Cancer Res. 2006;12:6643-6651. (Pubitemid 44876832)
13. Richards L. Staging and prognostic value of p16 expression in oropharyngeal cancer. Nat Rev Clin Oncol. 2010;7:358.
14. Rischin D, Young RJ, Fisher R, et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol. 2010;28:4142-4148.
15. Shi W, Kato H, Perez-Ordonez B, et al. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridi-zation for human oropharyngeal squamous carcinoma. J Clin Oncol. 2009;27: 6213-6221.